ProShares Ultra Nasdaq Biotechnology Rating $66.98 +0.77 (+1.16%) Closing price 10/24/2025 03:59 PM EasternExtended Trading$66.97 -0.01 (-0.01%) As of 10/24/2025 04:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock ProShares Ultra Nasdaq Biotechnology Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BIB Aggregate RatingModerate Buy 2.63Holdings in BIB have an aggregate rating of Moderate Buy based on 359 analyst ratings issued in the past year covering 19 companies (38.3% of the portfolio).BIB Aggregate Price Target$66.98High Prediction$66.98Average Prediction$66.98Low Prediction$66.98Holdings in BIB have an aggregate price target of $66.98 and a range of $66.98 to $66.98 covering 19 companies (38.3% of the portfolio).BIB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy11 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares Ultra Nasdaq Biotechnology Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 19 BIB Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.17%VRTXVertex Pharmaceuticals$421.39-0.3%4.8993 of 5 stars2.62$494.38 17.3%29Positive NewsAnalyst Forecast5.14%GILDGilead Sciences$120.94+0.2%4.9286 of 5 stars2.81$122.61 1.4%27Positive NewsUpcoming EarningsAnalyst Forecast4.87%AMGNAmgen$291.76-0.4%4.5795 of 5 stars2.28$300.94 3.1%18Positive NewsAnalyst Forecast3.49%ALNYAlnylam Pharmaceuticals$463.43-0.1%4.01 of 5 stars2.81$466.92 0.8%27Upcoming EarningsAnalyst Forecast3.46%REGNRegeneron Pharmaceuticals$577.95+0.4%4.8858 of 5 stars2.79$802.35 38.8%28Positive NewsUpcoming EarningsAnalyst Forecast2.50%AZNAstraZeneca$83.29-0.1%3.4157 of 5 stars2.60$86.00 3.3%5Positive NewsAnalyst ForecastShort Interest ↓1.96%INSMInsmed$159.66-0.3%3.066 of 5 stars2.86$152.88 -4.2%21News CoverageUpcoming EarningsAnalyst Forecast1.45%ARGXargenex$817.32+0.6%2.6927 of 5 stars2.92$817.53 0.0%24News CoverageUpcoming EarningsAnalyst Downgrade1.27%BIIBBiogen$149.89-0.1%4.7242 of 5 stars2.35$180.69 20.5%31Trending NewsUpcoming EarningsAnalyst UpgradeAnalyst Revision1.10%UTHRUnited Therapeutics$418.58-1.8%4.8436 of 5 stars2.57$461.62 10.3%14Positive NewsUpcoming EarningsAnalyst ForecastInsider Trade1.03%INCYIncyte$91.28+2.2%4.4853 of 5 stars2.32$84.79 -7.1%19Upcoming EarningsAnalyst Forecast0.99%MEDPMedpace$605.20+1.4%4.1499 of 5 stars1.88$464.00 -23.3%16Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision0.93%RPRXRoyalty Pharma$37.26+1.1%4.9772 of 5 stars3.00$46.00 23.5%5News CoveragePositive NewsDividend AnnouncementAnalyst DowngradeShort Interest ↓0.89%ILMNIllumina$100.11+0.1%4.6929 of 5 stars2.11$115.25 15.1%19Upcoming EarningsAnalyst Forecast0.87%TEMTempus AI$89.23+2.5%2.0891 of 5 stars2.38$79.38 -11.0%16Analyst DowngradeGap Up0.83%SMMTSummit Therapeutics$19.28+2.8%2.7968 of 5 stars2.50$31.14 61.5%18Trending NewsEarnings ReportAnalyst ForecastInsider TradeAnalyst RevisionGap Up0.83%NBIXNeurocrine Biosciences$144.00+0.2%4.3186 of 5 stars2.86$164.32 14.1%22Upcoming EarningsAnalyst Forecast0.80%SNYSanofi$51.64+4.3%4.2842 of 5 stars3.00$62.67 21.4%10Trending NewsEarnings ReportGap Up0.72%ROIVRoivant Sciences$18.22+0.6%2.8777 of 5 stars2.90$19.94 9.4%10Analyst Upgrade This page (NASDAQ:BIB) was last updated on 10/26/2025 by MarketBeat.com Staff From Our PartnersU.S. Government Sparking Crypto RallyMissed Bitcoin when it was $100? You’re not alone. Crypto runs in cycles—and the next one is already underw...Crypto 101 Media | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredElon Musk is on the lineElon Musk says November 6 could "affect the future of the world" Get ready for the biggest pivot in corpora...Altimetry | SponsoredTrump’s new nightmare beginsPorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredBuy the dip? Here’s my #1 gold stock“The most obvious opportunity in gold stocks I’ve seen in my career” While everyone is distracted by gold’s...Golden Portfolio | SponsoredThe strategy that wins no matter where the market goesJoel and Adam have built a crypto trading system with a 93% win rate — even through volatile, sideways markets...Crypto Swap Profits | SponsoredTrade this between 9:30 and 10:45 am ESTIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares Ultra Nasdaq Biotechnology Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares Ultra Nasdaq Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIB Stock Alerts